Healthcare -
Biotechnology - NASDAQ - US
$ 1.065
-4.05 %
$ 123 M
Market Cap
-11.83
P/E
CHRS - REVENUE
Revenue CHRS - Coherus BioSciences, Inc.
257 M
LAST VALUE
-11.24%
2 YEAR CAGR
177.76%
5 YEAR CAGR
57.43%
10 YEAR CAGR